Immunovant Inc (IMVT)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Immunovant*s Batoclimab Demonstrates Remarkable Efficacy in Phase 2 Trial for Graves Disease
Immunovant Inc Shows Promising Financial Performance in Q4 2023
Company Records Soaring Losses in Financial Year 2023, Exceeding Previous Year*s Figures
Immunovant Inc Faces Rising Business Costs, Posts Significant Operating Deficit in Q1 of FY 2023
The company announced operating shortfall in the first quarter of 2023